Research
Epitranscriptomics & Cancer Adaptation : A.David

Activities

Our research work focuses on the contribution of post-transcriptional mechanisms on cancer cell adaptation, in particular RNA epigenetic & translational control.

More..

Zotero public

Added by llasorsa
Group name EquipeMY
Item Type Journal Article
Title A straightforward method to quantify circulating mRNAs as biomarkers of colorectal cancer
Creator Grosgeorges et al.
Author Marie Grosgeorges
Author Laurence Picque Lasorsa
Author Brice Pastor
Author Corinne Prévostel
Author Evelyne Crapez
Author Cynthia Sanchez
Author Florence Frayssinoux
Author Marta Jarlier
Author Laure Monard
Author Marc Ychou
Author Alain R. Thierry
Author Thibault Mazard
Author Philippe Blache
Abstract Optimizing the biomarker combination to be analyzed in liquid biopsies should improve personalized medicine. We developed a method to purify circulating cell-free mRNAs from plasma samples and to quantify them by RT-qPCR. We selected three candidate colorectal cancer biomarkers (B2M, TIMP-1, and CLU). Their mRNA levels were significantly higher in plasma of patients with metastatic colorectal cancer patients (mCRC) (n?=?107) than in healthy individuals (HI) (n?=?53). To increase the discriminating performance of our method, we analyzed the sum of the three mRNA levels (BTC index). The area under the ROC curve (AUC) to estimate the BTC index capacity to discriminate between mCRC and HI plasma was 0.903. We also determined the optimal BTC index cut-off to distinguish between plasma samples, with 82% of sensitivity and 93% of specificity. By using mRNA as a novel liquid biopsy analytical parameter, our method has the potential to facilitate rapid screening of CRCm.
Publication Scientific Reports
Volume 13
Issue 1
Pages 2739
Date 2023-02-15
Journal Abbr Sci Rep
Language eng
DOI 10.1038/s41598-023-29948-4
ISSN 2045-2322
Library Catalog PubMed
Extra PMID: 36792801 PMCID: PMC9932139
Tags Biomarkers, Tumor, Colorectal Neoplasms, Humans, RNA, Messenger, ROC Curve
Date Added 2023/06/08 - 15:00:27
Date Modified 2024/10/10 - 16:26:19
Notes and Attachments PubMed entry (Attachment)
Texte intégral (Attachment)
Texte intégral (Attachment)


© Institut de Recherche en Cancérologie de Montpellier - 2011 - Tous droits réservés - Mentions légales - Connexion - Conception : ID Alizés